Trial Profile
A Single-Center, Open-Label, Single-Period, Single-Treatment Study to Determine the Mass Balance of a Single Oral Dose of 14C Labeled Lofexidine
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Feb 2022
Price :
$35
*
At a glance
- Drugs Lofexidine (Primary)
- Indications Opioid-related disorders
- Focus Pharmacokinetics
- Sponsors US WorldMeds
- 23 Apr 2015 This study is extension of study USWM-LX1-1003 which is not found in CTI.
- 23 Apr 2015 New trial record